Genomic correlates of clinical outcome in advanced prostate cancer
Genomic correlates of clinical outcome in advanced prostate cancer | PNAS
Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer - European Urology
Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features - Clinical Oncology
Genomic correlates of clinical outcome in advanced prostate cancer | PNAS
Prostate cancer | Nature Reviews Disease Primers
Genomic correlates of clinical outcome in advanced prostate cancer | PNAS
Epigenetic modulations and lineage plasticity in advanced prostate cancer - Annals of Oncology
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer - eBioMedicine
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer - eBioMedicine
Genomic correlates of clinical outcome in advanced prostate cancer | PNAS
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer - eBioMedicine
Clinical implications of genomic alterations in metastatic prostate cancer | Prostate Cancer and Prostatic Diseases
Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse | Nature Communications
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer | Prostate Cancer and Prostatic Diseases
Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis - ScienceDirect
Genomic correlates of clinical outcome in advanced prostate cancer | PNAS
Accelerating precision medicine in metastatic prostate cancer | Nature Cancer
PDF) Genomic correlates of clinical outcome in advanced prostate cancer
Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity - ScienceDirect
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer | BMC Medicine | Full Text
Prostate cancer - The Lancet
Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary - Urology
